Figure 7From: Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes Quantification of RNAi (black bars) and cell survival rates (gray bars) of HER2-positive SKBR3 and HER2-negative HeLa cells treated by siRNA combined with Z HER2 -BNC/LP (left side) and Z WT -BNC/LP (right side) (final conc. 25Â nM as siRNA). Back to article page